Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5727)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 14, 2024 (publication date) through Nov 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Yin JY, Yang TY, Yang BQ, Hou CX, Li JN, Li Y, Wang Q. FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. World J Gastroenterol 2024; 30(18): 2440-2453 [PMID: 38764767 DOI: 10.3748/wjg.v30.i18.2440] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Yin JY, Yang TY, Yang BQ, Hou CX, Li JN, Li Y, Wang Q. FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. World J Gastroenterol 2024; 30(18): 2440-2453 [PMID: 38764767 DOI: 10.3748/wjg.v30.i18.2440] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i18/2440.htm |
| Number | Citing Articles |
| 1 |
Sanad Dawod, Kimberly Brown. Non-invasive testing in metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1499013
|
| 2 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 3 |
Shuai Zhang, Hao Liang, Jun Liu, Zhipeng Huang, Xijing Shi, Ye Zhu. The association between inflammatory, metabolic, and hepatic fibrosis-related biomarkers and atrial fibrillation in older patients with metabolic dysfunction-associated steatotic liver disease. BMC Geriatrics 2025; 25(1) doi: 10.1186/s12877-025-06120-3
|
| 4 |
Jianing Shi, Xuan Wu, Jiali Yu, Qingli Zhou. Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1651357
|
| 5 |
Xiao-Xuan Tang, Rui Wu, Jun-Hui Chen, Feng-Lan Wang, Sai-Li Zhao, Jie Lu, Jian Qin, Duan-Ming Zhuang, Bin Zhang. Association between HOMA-IR and metabolic dysfunction-associated steatohepatitis in U.S. adults with MASLD. Metabolism Open 2025; 28: 100402 doi: 10.1016/j.metop.2025.100402
|
| 6 |
Florian Koutny, Vanessa Frey, Christian Datz, Sophie Gensluckner, Julian Prosenz, Patrick Langthaler, Andreas Maieron, Maria Flamm, Daniel Weghuber, Bernhard Iglseder, Eugen Trinka, Bernhard Paulweber, Elmar Aigner, Bernhard Wernly. Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 Study. Hepatology International 2025; doi: 10.1007/s12072-025-10922-3
|
| 7 |
Yilong Chen, Shuixiu Bian, Jiamei Le. Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives. Genes 2025; 16(4): 399 doi: 10.3390/genes16040399
|
| 8 |
Emre Hoca, Bilal Cangir, Süleyman Ahbab, Seher İrem Şahin, Ece Çiftçi Öztürk, Ayşe Öznur Urvasızoğlu, Nilsu Kalaycı, İsmail Engin, Hayriye Esra Ataoğlu. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients. Diagnostics 2025; 15(16): 2045 doi: 10.3390/diagnostics15162045
|